Crossmark

Differential expression of the miR-17-92 cluster and miR-17 family in breast cancer according to tumor type; results from the Norwegian Women and Cancer (NOWAC) study

Crossref DOI link: https://doi.org/10.1186/s12967-019-2086-x

Published Online: 2019-10-03

Published Print: 2019-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Moi, Line https://orcid.org/0000-0001-5282-2434
Braaten, Tonje

Al-Shibli, Khalid

Lund, Eiliv

Busund, Lill-Tove Rasmussen
Funding

Funding for this research was provided by:

Helse Nord RHF
License Information

Text and Data Mining valid from 2019-10-03

Version of Record valid from 2019-10-03
More Information

Article History

Received: 27 March 2019

Accepted: 24 September 2019

First Online: 3 October 2019

Ethics approval and consent to participate

: The study has been approved by the regional ethical committee of North Norway (Reference Number REK Nord 2010/1931, 2013/2271). The Data Inspectorate has also approved the storing of relevant, not identifiable data and the linkage to national registries in the NOWAC study.

: Not applicable.

: The authors declare that they have no competing interests.

Document is current

Any future updates will be listed below